AntineoplasticsExanthema, rash and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1935卷 / 1期

关键词：

D O I：

10.1007/s40278-022-28854-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：59 / 59

相关论文

共 50 条

[41] Anakinra/tocilizumabFlagellate dermatitis-like rash and lack of efficacy: case report
Reactions Weekly, 2023, 1984 (1) : 51 - 51
[42] Brimonidine/dorzolamide/timolol/cotrimoxazole/valaciclovirCutaneous rash and lack of efficacy: case report
Reactions Weekly, 2023, 1975 (1) : 89 - 89
[43] Infliximab/ipilimumab/methylprednisoloneAcneiform skin rash, diarrhoea and lack of efficacy: case report
Reactions Weekly, 2022, 1907 (1) : 257 - 257
[44] Alectinib/iodine-131Lack of efficacy, facial oedema and rash: case report
Reactions Weekly, 2023, 1953 (1) : 20 - 20
[45] Antineoplastics/folinic-acidAcquired resistance, rash, mucositis and lack of efficacy: case report
Reactions Weekly, 2022, 1929 (1) : 89 - 89
[46] Multiple drugsGrade 3 myelosuppression, grade 1 rash and lack of efficacy: case report
Reactions Weekly, 2025, 2054 (1) : 285 - 285
[47] Loperamide/octreotide/trametinibSkin rash, high stoma losses and lack of efficacy: case report
Reactions Weekly, 2023, 1973 (1) : 164 - 164
[48] Adrenergic receptor agonists/antiarrhythmicsFull body drug rash and lack of efficacy: case report
Reactions Weekly, 2020, 1800 (1) : 20 - 20
[49] IbrutinibPneumonia, rash and lack of efficacy: 3 case reports
Reactions Weekly, 2022, 1905 (1) : 242 - 242
[50] CarbamazepineDrug rash and lack of efficacy: 2 case reports
Reactions Weekly, 2024, 2027 (1) : 111 - 111

← 1 2 3 4 5 →